You are here

  • Home
  • Archive
  • Volume 11, Issue 9
  • Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer

Article metrics

Article menu

Download PDFPDF

Immunotherapy biomarkers
Original research
Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer

 

Online download statistics by month:

Online download statistics by month: September 2023 to July 2025

AbstractFullPdf
Sep 2023597600159
Oct 202347047396
Nov 202352752876
Dec 202352252381
Jan 202414414465
Feb 202413413463
Mar 202416816880
Apr 202412913084
May 202412312457
Jun 202411311359
Jul 202410811061
Aug 202411110955
Sep 2024108108212
Oct 202412012078
Nov 202413714178
Dec 202415015283
Jan 2025164168106
Feb 2025231231105
Mar 2025141141105
Apr 202511711760
May 2025888857
Jun 2025484927
Jul 2025110
Total445144721847